News Release
(For immediate release)
Krames On-Demand Infobutton named Allscripts® May 2017 App of the Month
Gives health care providers instant access to customizable patient-education materials
Yardley, PA (May 15, 2017) – StayWell, a leading health engagement solutions company, announced today that its Krames On-DemandTM Infobutton has been recognized by Allscripts as the May App of the Month. Krames On-Demand Infobutton is a StayWell solution that integrates recommended patient education into clinicians’ workflow, giving health care providers instant access to the Krames On-Demand library of patient education HealthSheets™, videos, discharge instructions, and more — with one click.
Krames On-Demand Infobutton was certified for integration within the Allscripts Electronic Health Record (EHR) solutions last year, and was recognized as App of the Month. When using Infobutton to access the Krames On-Demand library of content, health care providers can:
- Quickly and easily download award-winning patient education content, including videos and KidsHealth® instructions;
- Customize or create branded patient education materials;
- Access content from multiple locations within a health system; and
- Integrate custom content into existing health system content.
“Infobutton gives health care providers immediate access to tools they can use to engage patients in the care they receive, which has the potential to lead to better outcomes,” said JoAnna Brogdon, Vice President, Partner Development, StayWell. “We’re honored to be named Allscripts’ App of the Month because it reinforces the value Infobutton delivers to clinicians in a complex, competitive health care market.”
For more about the Krames On-Demand Infobutton, visit the Allscripts Application Store or join our webinar, “Integrated Engagement Solutions for Allscripts,” on May 31, 2017, at 1:00 p.m. EST.
###
About StayWell
StayWell is a health solutions company that uses the science of behavior change to help people live happier, healthier lives. StayWell brings decades of experience working across the health care industry to design solutions for improving individual and organizational health outcomes, managing the health of targeted populations, and creating brand engagement for employers and health care organizations. StayWell programs have received numerous top industry honors, including the C. Everett Koop National Health Award and the Web Health Award for health engagement programs. StayWell also has received URAC and NCQA accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (“Merck”). The company is headquartered in Yardley, PA, and also has a major location in St. Paul, MN. To learn more, visit http://www.staywell.com.
About Merck
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, YouTube and LinkedIn.
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of The StayWell Company, a subsidiary of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2016 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
Media contact for StayWell:
Barbara Tabor, APR / 651-230-9192 / barbara@taborPR.com
